# A Phase Ib/II Study of GT90001 Combined With KN046 in Solid Tumors

> **NCT04984668** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Suzhou Kintor Pharmaceutical Inc,** · enrollment: 216 (estimated)

## Conditions studied

- Solid Tumor

## Interventions

- **DRUG:** GT90001+KN046
- **DRUG:** GT90001+KN046
- **DRUG:** GT90001/KN046
- **DRUG:** GT90001+KN046
- **DRUG:** GT90001+KN046

## Key facts

- **NCT ID:** NCT04984668
- **Lead sponsor:** Suzhou Kintor Pharmaceutical Inc,
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-11-02
- **Primary completion:** 2025-04
- **Final completion:** 2025-12
- **Target enrollment:** 216 (ESTIMATED)
- **Last updated:** 2024-02-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04984668

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04984668, "A Phase Ib/II Study of GT90001 Combined With KN046 in Solid Tumors". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT04984668. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*